Overview

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes

Status:
COMPLETED

Trial end date:
2023-11-01

Target enrollment:

Participant gender:

Summary

This trial is conducted in China. The aim of the trial is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of mutiple-dose GZR4 in subjects with type 2 diabetes

Phase:

PHASE1

Details

Lead Sponsor:

Gan and Lee Pharmaceuticals, USA

Treatments:

insulin degludec